GSK GSK plc
Healthcare$51.50+0.23%ClosedMarket Cap: $103.57B
As of 2026-05-26
Valuation
P/E (TTM)
20.18
PEG
0.17
P/B
4.32
P/S
2.33
EV/EBITDA
7.96
DCF Value
$302.36
FCF Yield
6.6%
Div Yield
3.5%
Margins & Returns
Gross Margin
72.7%
Operating Margin
22.3%
Net Margin
17.8%
ROE
35.8%
ROA
9.3%
ROIC
13.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $7.63B | 75.4% | $2.29B | $1.74B | $— | $0.47 |
| Q4 null | $8.62B | 69.2% | $1.51B | $636.0M | $— | $0.43 |
| FY null | $32.67B | 72.4% | $8.34B | $5.72B | $— | $1.69 |
| Q3 null | $8.55B | 73.6% | $2.59B | $2.01B | $— | $0.43 |
| Q3 null | $8.55B | 73.6% | $2.59B | $2.01B | $— | $0.43 |
| Q2 null | $7.99B | 72.9% | $2.02B | $1.44B | $— | $0.43 |
| Q1 null | $7.52B | 74.2% | $2.22B | $1.62B | $— | $0.41 |
| Q4 null | $8.12B | 68.5% | $696.0M | $414.0M | $— | $0.38 |
| FY null | $31.38B | 71.2% | $4.02B | $2.58B | $— | $1.56 |
| Q3 null | $8.01B | 70.1% | $189.0M | $-58.0M | $— | $0.39 |
| Q2 null | $7.88B | 73.1% | $1.65B | $1.17B | $— | $0.38 |
| Q1 null | $7.36B | 73.2% | $1.49B | $1.05B | $— | $0.40 |